Shu-Hong Zhang

Title: Innovations of Shu-Hong Zhang

Introduction

Shu-Hong Zhang is a notable inventor based in Groton, CT (US). He has made significant contributions to the field of chemistry, particularly in the development of retroviral protease inhibitors. With a total of 5 patents to his name, his work has had a substantial impact on pharmaceutical research and development.

Latest Patents

One of his latest patents involves a method of preparing retroviral protease inhibitor intermediates. This method utilizes chiral hydroxyethylamine, hydroxyethylurea, or hydroxyethylsulfonamide isostere containing retroviral protease and renin inhibitors. The invention describes a cost-effective approach to obtaining key chiral amine intermediates that are enantiomerically, diastereomerically, and chemically pure. Furthermore, the method is suitable for large-scale (multikilogram) productions and encompasses organic acid and inorganic acid salts of the amine intermediates.

Career Highlights

Shu-Hong Zhang is currently associated with G.D. Searle & Company, where he continues to innovate and contribute to the field of medicinal chemistry. His expertise in synthesizing complex chemical compounds has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout his career, Shu-Hong Zhang has collaborated with several esteemed colleagues, including John S. Ng and Claire S. Przybyla. These collaborations have further enhanced his research and development efforts in the field.

Conclusion

Shu-Hong Zhang's contributions to the field of chemistry, particularly in the area of retroviral protease inhibitors, demonstrate his innovative spirit and dedication to advancing pharmaceutical science. His work continues to influence the development of effective treatments in the medical field.